lunedì, 4 maggio 2026

Notizie AIOM – anno XV

European Commission Approves Oral Rolapitant for CINV

April 26, 2017 - The European Commission has approved oral rolapitant tablets for the treatment of delayed chemotherapy-induced nausea and vomiting (CINV) in adults. The approval applies to all 28 EU member states as well as in the European Economic Area (EEA) countries ...
Leggi tutto

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor. We aimed to assess the safety and efficacy of nivolumab, a programmed cell death protein-1 (PD-1) immune checkpoint inhibitor, in patients with advanced ...
Leggi tutto

Tyrosine kinase-targeting drugs-associated heart failure

The impact of cancer therapies on cardiac disease in the general adult cancer survivor population is largely unknown. Our objective was to evaluate which tyrosine kinase-targeting drugs are associated with greater risk for new-onset heart failure (HF). A nested case–control ...
Leggi tutto

Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer

Evaluate literature to assess response rate as a surrogate endpoint of survival in ovarian cancer (OC). Systematic review consistent with PRISMA criteria, identified randomized, controlled trials reporting overall survival (OS), progression-free survival (PFS), and objective ...
Leggi tutto

Improving Access to Cancer Treatments: The Role of Biosimilars

Biologics play a key role in cancer treatment and are principal components of many therapeutic regimens. However, they require complex manufacturing processes, resulting in high cost and occasional shortages in supply. The cost of biologics limits accessibility of cancer ...
Leggi tutto

Premi per incentivare la ricerca di specialisti in Oncologia e Geriatria

Il Gruppo Italiano di Oncologia Geriatrica - GIOGer, istituisce tre premi di 1.000 euro netti ciascuno, che saranno conferiti in occasione del prossimo Congresso nazionale di Oncologia Geriatrica che si terrà a Lecce il 15 e 16 Settembre 2017. Scadenza delle domande: ...
Leggi tutto

24 aprile 2017 – AIFA. “La vaccinovigilanza in Italia: ruolo ed obiettivi”

24 aprile 2017 – Innovazione sostenibile: le polemiche sul nuovo budget NICE e la via italiana

24 aprile 2017 – Modalità per la presentazione di richieste di autorizzazione delle Sperimentazioni Cliniche e di Emendamenti Sostanziali di Fase I-II-III-IV

27 aprile 2017 – Comitato per i Medicinali per Uso umano (CHMP) dell’EMA: highlights del meeting di aprile